Assertio Therapeutics Inc

Assertio Holdings, Inc. is a pharmaceutical company that provides various products to patients in the United States. Its products include INDOCIN for moderate to severe rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, acute painful shoulder, and gouty arthritis; Sympazan for seizures associated with Lennox-Gastaut syndrome in patients aged two years or older; CAMBIA for migraine pain, nausea, photophobia, and phonophobia; SPRIX for short-term management of moderate to moderately severe pain; and ROLVEDON to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. It was incorporated in 2020 and is headquartered in Lake Forest, Illinois.